Drug Profile
Imalumab - Takeda
Alternative Names: Anti-macrophage migration inhibitory factor antibody - Takeda; Anti-MIF monoclonal antibody - Takeda; BAX-069; BAX-69Latest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Cytokine PharmaSciences
- Developer Baxalta; Shire; Takeda
- Class Antibodies; Antineoplastics; Immunotherapies; Monoclonal antibodies; Urologics
- Mechanism of Action Immunomodulators; Macrophage migration inhibitory factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Colorectal cancer; Lupus nephritis; Malignant ascites; Solid tumours
Most Recent Events
- 15 Apr 2021 Discontinued - Phase-I for Solid tumours (Metastatic disease) in USA (IV)
- 15 Apr 2021 Discontinued - Phase-I for Solid tumours in Germany (IV)
- 15 Apr 2021 Discontinued - Phase-I/II for Malignant ascites (Recurrent) in Hungary (Intraperitoneal)